Effects of polyethylene and TiAIV wear particles on expression of RANK, RANKL and OPG mRNA

Acta Orthopaedica Scandinavica

Volumn 75, Issue 3, 2004, Pages 295-302

  Baumann, Bernd ^a   Rader, Christof P ^a   Seufert, Jochen ^b   Nöth, Ulrich ^a   Rolf, Olaf ^a   Eulert, Jochen ^a   Jakob, Franz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POLYETHYLENE; TITANIUM; TUMOR NECROSIS FACTOR ALPHA; ALLOY; CARRIER PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERIAL COATING; MONOCYTE; NUCLEOTIDE SEQUENCE; PROSTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; FOREIGN BODY; GENETICS; OSTEOCLAST;

ALLOYS; CARRIER PROTEINS; CELLS, CULTURED; FOREIGN BODIES; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; POLYETHYLENE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TITANIUM;

EID: 3042569601     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470410001222     Document Type: Article

References (30)

1. Auwerx J. The human leukemia cell line, THP-1: a multi-facetted model for the study of monocyte-macrophage differentiation. Experientia 1991; 47: 22-31.
2. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000; 275: 4858-64.
3. Bi Y, Seabold J M, Kaar S G, Ragab A A, Goldberg V M, Anderson J M, Greenfield E M. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 2001; 16: 2082-91.
4. Brooks R A, Wimhurst J A, Rushton N. Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. J Bone Joint Surg (Br) 2002; 84: 295-9.
5. Campbell P, Ma S, Yeom B, McKellop H, Schmalzried T P, Amstutz H C. Isolation of predominantly submicronsized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995; 29: 127-31.
6. Chiang C Y, Kyritsis G, Graves D T, Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 1999; 67: 4231-6.
7. Cho D R, Shanbhag A S, Hong C Y, Baran G R, Goldring S R. The role of adsorbed endotoxin in particle-induced stimulation of cytokine release. J Orthop Res 2002; 20: 704-13.
8. Goater J J, O'Keefe R J, Rosier R N, Puzas J E, Schwarz E M. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 2002; 20: 169-73.
9. Goodman S B, Lind M, Song Y, Smith R L. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop 1998; 352: 25-34.
10. Harris W H. The problem is osteolysis. Clin Orthop 1995; 311: 46-53.
11. Haynes D R, Crotti T N, Potter A E, Loric M, Atkins G J, Howie D W, Findlay D M. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg (Br) 2001; 83: 902-11.
12. Hirakawa K, Bauer T W, Stulberg B N, Wilde A H. Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res 1996; 31: 257-63.
13. Hofbauer L C, Lacey D L, Dunstan C R, Spelsberg T C, Riggs B L, Khosla S. Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999; 25: 255-9.
14. Itonaga I, Sabokbar A, Murray D W, Athanasou N A. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann Rheum Dis 2000; 59: 26-31.
15. Jacobs J J, Roebuck K A, Archibeck M, Hallab N J, Glant T T. Osteolysis: basic science. Clin Orthop 2001; 393: 71-7.
16. Kadoya Y, Kobayashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand (Suppl 278) 1998: 1-16.
17. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5.
18. Kong Y Y, Yoshida H, Sarosi I, Tan H L, Timms E, Capparelli C, Morony S, Oliveira-Dos-Santos A J, Van G, Itie A, Khoo W, Wakeham A, Dunstan C R, Lacey D L, Mak T W, Boyle W J, Penninger J M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 1999; 397: 315-23.
19. Kubo T, Sawada K, Hirakawa K, Shimizu C, Takamatsu T, Hirasawa Y. Histiocyte reaction in rabbit femurs to UHMWPE, metal, and ceramic particles in different sizes. J Biomed Mater Res 1999; 45: 363-9.
20. Lam J, Takeshita S, Barker J E, Kanagawa O, Ross F P, Teitelbaum S L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106: 1481-8.
21. Maloney W J, Smith R L, Schmalzried T P, Chiba J, Huene D, Rubash H. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg (Am) 1995; 77: 1301-10.
22. Merkel K D, Erdmann J M, McHugh K P, Abu-Amer Y, Ross F P, Teitelbaum S L. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 1999; 154 (1): 203-10.
23. Rader C P, Baumann B, Sterner T, Rolf O, Hendrich C, Schutze N, Jakob F. TNF-alpha secretion by human macrophage-like cells in response to wear particles and its modification by drugs. Biomed Tech (Berl) 1999a; 44: 135-41.
24. Rader C P, Sterner T, Jakob F, Schutze N, Eulert J. Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles. J Arthroplasty 1999b; 14: 840-8.
25. Rader C, Baumann B, Rolf O, Radke S, Hendrich C, Schutze N, Seufert J, Jakob F. Detection of differentially expressed genes in particle disease using array-filter analysis. Biomed Tech (Berl) 2002; 47: 111-6.
26. Sabokbar A, Kudo O, Athanasou N A. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. J Orthop Res 2003; 21: 73-80.
27. Shanbhag A S, Jacobs J J, Glant T T, Gilbert J L, Black J, Galante J O. Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg (Br) 1994; 76: 60-7.
28. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie M T, Martin T J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-57.
29. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-6.
30. Yasuda H, Shima N, Nakagawa N, Mochizuki S I, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139: 1329-37.